Pimekrolimuusi

Pimekrolimuusi is a medication used to treat mild to moderate atopic dermatitis, also known as eczema. It belongs to a class of drugs called topical calcineurin inhibitors. Unlike corticosteroids, pimekrolimuusi works by suppressing the immune system's inflammatory response in the skin without causing the thinning or other side effects commonly associated with long-term steroid use. It is applied as a cream directly to the affected areas of the skin. The active ingredient, pimekrolimuusi, inhibits the activation of T-lymphocytes, which are key players in the inflammatory process of eczema. This reduces redness, itching, and swelling. Pimekrolimuusi is generally prescribed for individuals who have not responded well to other treatments or where long-term corticosteroid use is undesirable. It is typically used as a short-term or intermittent long-term therapy. Common side effects can include temporary burning, itching, or stinging at the application site. It is important to use pimekrolimuusi as directed by a healthcare professional.